New stock news | New Lotus Flower submits documents to Hong Kong Stock Exchange three times
According to the prospectus, XinHeHua is a major supplier of Chinese herbal medicine product in China.
According to the disclosure by the Hong Kong Stock Exchange on April 30, Sichuan Xinhua Herbal Medicine Co., Ltd. (referred to as "Xinhua") has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with GF SEC (Hong Kong) and ICBC International as joint sponsors. The company had previously submitted listing applications to the Hong Kong Stock Exchange on April 3, 2025, and October 17, 2025. According to the prospectus, Xinhua is a major supplier of Chinese herbal medicine products. According to data from Frost & Sullivan, based on the revenue of Chinese herbal medicine products in 2024, Xinhua is ranked second in China, holding a 0.4% market share in the fiercely competitive market landscape, while the top five market participants collectively hold a 2.7% market share.
Related Articles
China Tower (00788): Li Zhangting resigns as supervisor
On May 6th, BEKE-W(02423) spent approximately $2 million to repurchase 321,000 shares.
On May 7th, 7ROAD (00797) spent HKD 95,000 to repurchase 160,000 shares.
China Tower (00788): Li Zhangting resigns as supervisor
On May 6th, BEKE-W(02423) spent approximately $2 million to repurchase 321,000 shares.
On May 7th, 7ROAD (00797) spent HKD 95,000 to repurchase 160,000 shares.
